Skip to content

Impact of Neuromodulation on Language Impairments in Stroke Patients

Impact of Neuromodulation on Language Impairments in Stroke Patients: a Multimodal Double-blind Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03699930
Enrollment
24
Registered
2018-10-09
Start date
2018-01-01
Completion date
2023-01-01
Last updated
2023-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia, Stroke

Keywords

transcranial direct current stimulation, stroke, aphasia, speech therapy, neurorehabilitation, neuromodulation, language function, neuroplasticity, neuroimaging, EEG, MRI, genetics, language disorders

Brief summary

Up to 40% of stroke survivors suffer from aphasia, making recovery of language abilities a top priority in stroke rehabilitation. Conventional speech and language therapy may have limited effectiveness. Leveraging multimodal data (behavioral, neuroimaging, and genetics), this study aims to 1) evaluate the efficacy of combining tDCS with speech therapy, 2) examine neural changes associated with recovery, 3) identify factors influencing response to treatment.

Detailed description

Approximately one million people in the United States are living with aphasia, an acquired neurological disorder affecting the ability to use and/or understand language. This communication impairment affects up to 40% of stroke patients. Stroke victims usually prioritize speaking, writing, and walking as the three most important rehabilitation goals, two of these goals therefore involving communication. Conventional speech therapy strategies have nevertheless limited effectiveness in post-stroke aphasia. Indeed, approximately half of those affected will remain in this state despite intensive speech therapy. Effective novel treatment is therefore warranted to improve recovery in these patients. Recent evidence suggests that transcranial direct current stimulation (tDCS), a non-invasive, low-cost neuromodulation technique, applied in conjunction with speech therapy may be more effective in promoting language recovery than behavioral intervention alone. A double-blind quasi-randomized controlled study will be carried out in chronic post-stroke aphasics. Participants will be assigned to either the tDCS group or to the sham (placebo) group and will receive 20 minutes of concurrent speech and language therapy by a trained speech therapist over five consecutive days. Behavioral, EEG, and MRI data will be acquired within one week before and after intervention. Genetic samples will be collected once. Secondary behavioral outcome measures will be performed again 3 months following tDCS/sham intervention to assess long-term benefits.

Interventions

DEVICEtDCS

Anodal or sham tDCS will be applied to the scalp.

A trained speech pathologist will administer the speech and language therapy.

Sponsors

Casa Colina Hospital and Centers for Healthcare
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

The only person knowing about this assignment will be the Principal Investigator.

Intervention model description

double-blind quasi-randomized controlled design

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Between ages 18-85 * At least 12 months post stroke * Diagnosed with aphasia due to ischemic or hemorrhagic stroke * English speaking * Right handed prior to stroke

Exclusion criteria

* Nonverbal * Other neurological diseases/disorders * Not MRI-compatible (e.g. claustrophobia, metal implants in the head)

Design outcomes

Primary

MeasureTime frameDescription
Change in Western Aphasia Battery-Revised scoresAt baseline and at week 3WAB-R is an instrument for assessing the language function of adults with suspected neurological disorders as a result of a stroke.

Secondary

MeasureTime frameDescription
Change in Patient-Reported Outcomes Measurement Information System (PROMIS)At baseline, at week 3, and at week 17PROMIS is used to assess physical, mental, and social health.
Change in Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)At baseline, at week 3, and at week 17The SAQOL-39 is used to assess health-related quality of life in people with long-term aphasia.
Change in Communication Outcomes after Stroke (COAST)At baseline, at week 3, and at week 17The COAST is used to assess self-perceived communication effectiveness for people with aphasia.
Change in resting state Electroencephalograph (EEG) signalsAt baseline and at week 3Using a B-Alert wireless EEG system, we will perform eyes-open resting-state EEG recordings to assess power spectral density changes.
Change in Test of Nonverbal Intelligence (TONI-4)At baseline and at week 3TONI-4 is a language-free intelligence test for evaluating those with limited language ability.
Change in Magnetic Resonance Imaging (MRI)At baseline and at week 3MRI scans will be acquired on a Siemens Magnetom Verio 3T Scanner at Casa Colina Imaging Center to assess structural changes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026